We believe in equal access to healthcare diagnostics for everyone, everywhere!
We are passionate about enabling more convenient solutions for patient centric sampling, ensuring more reliable test results for healthcare and other providers of tests based on blood or plasma. We believe in equal access to healthcare diagnostics for everyone, everywhere!
Want to learn more?
Projects & Collaborations
Since 2002, Attana research services and systems have improved their customers’ clinical trial success rates by 4x compared to the industry average. In 2021, they launched their first CE IVD-marked device for novel insights into antibody diagnostics. From a drop of blood (10µl), the AVATM laboratory system can both quantify the number of antibodies in a sample as well as determine their neutralizing capacity, in a matter of minutes. In combination with Capitainer® qDBS, Attana today offers high quality diagnostic analyses in a wider scope of studies than previously possible.
For more information visit www.attana.com
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No H2020-SEMINST-868807.